Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study highlights role of cellular forces in progression of cardiovascular disease

Clogging of pipes leading to the heart is the planet's number one killer. Surgeons can act as medical plumbers to repair some blockages, but we don't fully understand how this living organ deteriorates or repairs itself over time.

27 Apr 2012

Researchers define structure of key part of human obesity receptor

Medical researchers at the University of Sheffield have defined the structure of a key part of the human obesity receptor- an essential factor in the regulation of body fat- which could help provide new treatments for the complications of obesity and anorexia.

27 Apr 2012

Heart can regulate energy balance throughout the body

UT Southwestern Medical Center researchers have demonstrated for the first time that the heart can regulate energy balance throughout the body, a finding that may point to more effective treatments for obesity, diabetes, and heart disease.

27 Apr 2012

Diabetes alone may cost a sixth of total NHS budget by 2035: Report

A new report warns that diabetes will cost the NHS more than a sixth of its entire budget by 2035. The disease accounts for 10 per cent (£9.8 billion) of NHS spending, but this is projected to rise to £16.9 billion over the next 25 years, or 17 per cent of the health service's funds. There are around 3.8 million people living with diabetes in the UK and this is expected to increase to 6.25 million in just over two decades.

26 Apr 2012

Aspirin reduces bowel cancer death and lung cancer incidence: Research suggests

There is previous evidence suggesting aspirin might prevent certain cancers from developing in the first place. And more recent work suggests it might also work as a cancer therapy - slowing down or preventing a cancer's spread. But the drug can also have unpleasant and dangerous side effects, causing irritation of the stomach lining and internal bleeds in a very small minority of patients.

26 Apr 2012

FDA issues complete response letter to Takeda’s NDAs for type 2 diabetes investigational therapies

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. today announced that the company received a complete response letter from the United States (U.S.) Food and Drug Administration (FDA) regarding New Drug Applications (NDAs) for alogliptin and fixed-dose combination (FDC) alogliptin and pioglitazone.

26 Apr 2012

Kv7.4 channels may play a fundamental role in high blood pressure

Scientists have identified what could be a biological tipping point in the development of high blood pressure, in a discovery that could one day lead to new treatment.

26 Apr 2012

EuroPRevent2012 to take place from May 3-5 in Dublin

EuroPRevent2012, the premier European event on cardiovascular disease (CVD) prevention, brings together the latest guidelines and studies focused on reducing the global epidemic of heart disease.

26 Apr 2012

Dark chocolate good for the heart: Study

A new study finds that dark chocolate may lower the risk of heart disease by lowering levels of blood glucose and bad cholesterol while boosting levels of good cholesterol.

25 Apr 2012

London School of Hygiene & Tropical Medicine launches Centre for Global Non-Communicable Diseases

The Centre for Global Non-Communicable Diseases, a unique initiative that brings together researchers, policy makers, funders and patient advocacy groups worldwide to focus research and expertise on this growing global health challenge, is launched today (25 April) at the London School of Hygiene & Tropical Medicine.

25 Apr 2012

Vitamin D supplementation in winter can help lower blood pressure in hypertensive patients

A new study, presented at the European Society of Hypertension meeting in London, shows that vitamin D supplementation in winter can help lower blood pressure in patients with hypertension.

25 Apr 2012

Omega-3 supplements do not improve diastolic function in older adults

Over the past three decades, researchers have firmly established that the omega-3 fatty acids in fish oil, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have healthy effects on the heart. Omega-3 fatty acids seem to help both in preventing cardiovascular disease as well as in preventing future heart attacks, strokes, and other adverse events in people who have established cardiovascular disease.

25 Apr 2012

Book aims to improve overall cardiovascular health of its readers

Dr. Antonio M. Gotto Jr., dean emeritus and co-chairman of the board of overseers at Weill Cornell Medical College, is the co-author of a new book called The Living Heart in the 21st Century. The book, a new edition in The Living Heart best-selling series, is the essential resource guide for patients about cardiovascular disease prevention and treatment.

25 Apr 2012

Dark chocolate may reduce risk of cardiovascular disease

Chocolate, considered by some to be the "food of the gods," has been part of the human diet for at least 4,000 years; its origin thought to be in the region surrounding the Amazon basin. Introduced to the Western world by Christopher Columbus after his fourth voyage to the New World in 1502, chocolate is now enjoyed worldwide. Researchers estimate that the typical American consumes over 10 pounds of chocolate annually, with those living on the west coast eating the most. Wouldn't it be great if only chocolate were considered healthy?

25 Apr 2012

PET/CT could help improve prediction of heart attack

An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.

25 Apr 2012

Severe fibrosis increases early atherosclerosis risk in patients with chronic HCV-1 infection

Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty liver disease also increases risk of developing atherosclerosis at an earlier period. Both studies appear in the May issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

25 Apr 2012

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

23 Apr 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study highlights role of cellular forces in progression of cardiovascular disease

Researchers define structure of key part of human obesity receptor

Heart can regulate energy balance throughout the body

Diabetes alone may cost a sixth of total NHS budget by 2035: Report

Aspirin reduces bowel cancer death and lung cancer incidence: Research suggests

FDA issues complete response letter to Takeda’s NDAs for type 2 diabetes investigational therapies

Kv7.4 channels may play a fundamental role in high blood pressure

EuroPRevent2012 to take place from May 3-5 in Dublin

Dark chocolate good for the heart: Study

London School of Hygiene & Tropical Medicine launches Centre for Global Non-Communicable Diseases

Vitamin D supplementation in winter can help lower blood pressure in hypertensive patients

Omega-3 supplements do not improve diastolic function in older adults

Book aims to improve overall cardiovascular health of its readers

Dark chocolate may reduce risk of cardiovascular disease

PET/CT could help improve prediction of heart attack

Severe fibrosis increases early atherosclerosis risk in patients with chronic HCV-1 infection

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

RVX-208 molecule increases apolipoprotein A-I production

Intrinsically disordered protein responsible for inactivating BK channel

Herpes zoster vaccine safe and well tolerated: Study

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in